Still hungry on Mounjaro 5mg? Here's what's actually happening

Step 1, understand where 5mg actually sits in the dose schedule

Mounjaro's licensed titration schedule runs from 2.5mg through to 15mg across six steps, each held for roughly four weeks to let your system adjust. The 5mg pen is step two. The 5mg dose is not a maintenance dose; it is a stepping stone. Eli Lilly designed the early doses primarily to manage tolerability (reducing the nausea and digestive discomfort that can arrive when the medicine is introduced) rather than to deliver the full therapeutic effect on appetite.

In clinical practice, and supported by the trial data underpinning NICE's appraisal of tirzepatide, the hunger-reduction effect accumulates as the dose rises. Many people describe the shift as gradual: a little less interest in food at 5mg, noticeably less at 7.5mg or 10mg, and a qualitative change in how hunger feels at higher doses. If you are coming from a 2.5mg pen where you felt almost nothing, a partial improvement at 5mg is progress, even if it doesn't feel dramatic. The NHS medicines page for tirzepatide notes that the dose is individually titrated by a prescriber, and that effect builds with time.

A quick check worth doing: note your hunger on a simple scale of 1–10 at the same time each day for a week. If the average is lower than it was at 2.5mg, the medicine is working, just not yet at full effect. That one-minute habit gives you something concrete to share with your prescriber rather than a vague feeling.

Step 2, rule out the lifestyle factors that blunt the medicine's effect

Tirzepatide works partly by slowing gastric emptying and partly by acting on GIP and GLP-1 receptors to reduce appetite signalling. But neither mechanism overrides a calorie surplus driven by ultra-processed, low-protein, high-sugar foods, which are digested quickly and bypass the slower gastric-emptying effect almost entirely. If your meals are heavily refined-carbohydrate-led, you may feel genuinely hungry again within an hour or two even on a higher dose.

Protein is the most relevant dietary lever at this stage. It has the highest satiety-per-calorie profile of the three macronutrients and keeps gastric emptying slow in a way that works alongside what the medicine is already doing. Aim to anchor every main meal around a protein source (eggs, fish, lean meat, Greek yoghurt, pulses) before anything else on the plate. Hydration matters too: thirst is frequently misread as hunger, and mild dehydration is common on GLP-1 treatment when GI symptoms reduce appetite for fluids as well as food.

Sleep is the variable people most often overlook. Poor sleep raises ghrelin (the hormone that signals hunger) and blunts the appetite-suppressing signals that tirzepatide is trying to amplify. A rough night can make 5mg feel like 2.5mg. None of this replaces a dose review, but addressing these factors first means your next prescriber conversation is based on cleaner evidence. The full Mounjaro overview has more on how the medicine works alongside lifestyle changes.

Step 3, know when hunger at 5mg is a signal to contact your prescriber

There are two different situations to distinguish. The first is ongoing hunger that is improving week by week, that is titration working as intended, and the appropriate response is patience plus the lifestyle groundwork above. The second is hunger that is completely unchanged from before you ever started the medicine, persisting through the full four weeks of 5mg without any shift at all. That second picture is worth raising before your next scheduled review.

A prescriber may consider whether you are on the right medicine for your profile, whether there are absorption factors at play, or simply whether moving to 7.5mg is appropriate. Some people find the appetite effect becomes meaningful only at 7.5mg, and there is nothing unusual about that. The six-step schedule exists precisely because individual response varies. What a prescriber should not be doing (and what you should not be doing yourself) is changing timing, frequency or dose without clinical guidance. The dosing schedule is set out in the Mounjaro Patient Information Leaflet and on the NHS tirzepatide medicines page; both are clear that changes are made with a clinician, not unilaterally.

If you're wondering whether hunger at this dose means you should jump to a higher dose straight away, the question of the 'golden dose' is one our prescribers address regularly, there is no universal answer, but there is usually a clinical one. You can also explore how tirzepatide fits into a broader weight-management approach if you want the wider picture before your next review.

What the evidence says about hunger at mid-range doses

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults and found that the greatest weight reduction (around 20–21% on average at 15mg over 72 weeks) occurred at the highest studied doses. NICE's appraisal of tirzepatide (TA1026) draws on this and related data when setting the recommendation framework. Neither the trial nor the guidance treats 5mg as an end point. The appetite effect in early titration doses is deliberately partial.

This matters because it shifts the question from "why isn't it working" to "how much further does this go". For most people, the answer is: considerably further, once the dose reaches the 10mg–15mg range. People at 15mg and those at 12.5mg sometimes still report hunger, though of a different character, background awareness rather than the driving urge that dominates at lower doses. If you are at 5mg and feeling frustrated, that is a reasonable response. The medicine is real; the effect at this dose is incomplete by design.

If the cost of staying on treatment through the titration journey is a factor, it is worth reading about how UK Mounjaro pricing works so you are not making dose decisions based on incomplete cost information. When you are ready to speak to a prescriber about where you are in your journey, check your eligibility with our clinical team, a real prescriber reviews your consultation, not an automated system.